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ABSTRACT 
Microsponge delivery system is a unique and effective technology for the controlled release of topical agents. It is highly cross- linked porous, 
polymeric microspheres that can entrap wide range of active agents and in response to trigger or stimuli and release them onto the skin over a 
time. It consists of micro-porous beads, typically 5-300µm in diameter that acquire the flexibility to entrap a wide variety of active ingredients 
such as fragrances, sunscreens, emollients, anti-fungal, anti-infective, and anti-inflammatory agents etc., that are mostly used to prolong the 
topical administration of the drug . Recently it was investigated that microsponges also used for oral drug delivery system. The topical agent 
formulation with microsponge delivery system can be prepared in many different forms, such as cream, gel, or lotion. When the formulation is 
applied to the skin, the MDS releases its active ingredients on a time and in response to other stimuli (rubbing, temperature, pH etc.). They 
reduce side effects, enhance stability and modify drug release. Because of the size of the microsponges they cannot pass through the stratum 
corneum, so they remain on the skin surface and slowly releasing the active ingredients over a period. Slow rate of release from MDS reduce the 
irritancy associated with the topical agents. Slow and gradual release pattern of MDS prevents excessive build-up of the active agents in the 
epidermis and dermis. Therefore, these particles, remains on the surface of the skin and its fine lines delivering the active over prolonged time.                                                                       
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INTRODUCTION 
Microsponge is Novel technology, which provides extended 
release of pharmaceutical active ingredients 1, 2 and mostly 
used for topical formulations. In 1987, Won was developed 
the microsponge technology and the original patents were 
authorized by Advanced Polymer System, Inc.3 .Now a day 
the major challenge to the pharmaceutical industry is to 
control the delivery rate of active pharmaceutical ingredient 
to a pre-determined site. So to improve efficacy, patient 
compliance and modify drug release researcher focused on 
designing of different controlled release drug delivery 
systems. Microsponge having a myriad of interconnected 
voids of particle size ranging from 5-150 μm.4. The main 
purpose of Microsponge drug delivery system is to achieve 
desired concentration of the drug in blood in which is 
therapeutically more effective and non-toxic for long period 
of time in the recent study. A typical 25 μm sphere can have 
up to 250000 pores and have an internal pore structure 
equivalent to 10 feet in length and this results in a large 
reservoir type system within each microsponge, which can 
be loaded with up to its own weight of the active agent. The 
microsponge particles are too large to be absorbed into the 
skin5, 6. 
Microsponges have the capacity to entrap a wide range of 
active ingredients such as emollients, fragrances, essential 
oils, anti-fungal and anti-infective etc. are used as a topical 
carrier system7, 8.  Various methods for preparation of 
microsponge drug delivery systems studied9. 
POTENTIAL FEATURES OF MICROSPONGE DRUG 
DELIVERY SYSTEM9, 10: 
1. Stable over a pH range of 1 to 11. 
2. Stable up to 1300C temperature. 
3. Free flowing and cost effective. 
4. Higher pay load (50-60%). 
5. Compatible with the many of the vehicles and 
ingredients. 
6. Self sterilizing as their average pore size is 
0.25micrometer where bacteria cannot penetrate. 
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7. Can absorb oil up to 6 times their weight without 
drying. 
8. Reveal good compatibility with various vehicles and 
ingredients. 
BENEFITS OF MICROSPONGE TECHNOLOGY11: 
 Enhanced product performance. 
 Extended release. 
 Improved thermal, physical, and chemical stability. 
 Reduced irritation and hence improved patient 
compliance. 
 Improved product elegancy. 
 Flexibility to develop novel product forms. 
 Microsponge systems are non-irritating, non-
mutagenic, non-toxic and non-allergenic. 
 Allows incorporation of immiscible substances. 
 Improved formulation flexibility. 
CHARACTERISTICS OF THE MATERIALS 
ENTRAPPED IN MICROSPONGES12, 13: 
Soluble ingredients or liquids can be entrapped in the 
particles. Actives that can be entrapped in microsponges 
must meet following requirements: 
 It should be slightly soluble or water immiscible. 
 It should be either fully miscible in monomer or 
capable of being made miscible in monomer by 
addition of small amount of a water immiscible solvent. 
 It should be inert to monomers. 
 It should be stable in contact with polymerization 
catalyst and conditions of polymerization 
 To avoid cosmetic problems the solubility of actives in 
the vehicle must be limited; not more than 10 to 12% 
w/w microsponges must be incorporated into the 
vehicle. Otherwise the vehicle will deplete the 
microsponges before the application. 
 
 
MECHANISM OF ACTION14, 15: 
The active ingredients are added to the vehicle in an entrapped form 
 
The active is free to move in and out from particles and into the vehicle as they have an open structure and the vehicle becomes 
saturated at equilibrium state 
 
Once the product is applied to the skin, the active will be absorbed into the skin, depleting the vehicle, which becomes 
unsaturated, thus disturbing the equilibrium. 
 
A flow of microsponge particle to vehicle and from vehicle to skin, until the vehicle is either absorbed or dried. 
 
RELEASE MECHANISM16, 17, 18: 
A variety of triggers can cause further release of the 
substances from the microsponges. These triggers include 
pressure, solubility and change in temperature16, 17. 
Pressure: 
 Physical rubbing of the product against the skin exerts 
pressure and increases the release of the active ingredients 
from the beads, pores closets to the surface of the skin.  
Pressure thereby increases the amount of entrapped active 
material on the skin, enhancing the amount of entrapped 
active substance available. 
Temperature:  
Substances that are viscous at room temperature are unable 
to leave the microsponge spontaneously, can become less 
viscous when warmed to skin temperature, allowing them to 
flow onto the skin. 
Solubility:  
 The solubility of the entrapped ingredient can be used to 
regulate its diffusion from the microsponge. For e.g. 
Microsponge loaded with water miscible ingredients will 
release the ingredient in the presence of water. This release 
from microsponge may be achieved based on the ability of 
the external medium to dissolve the active, the 
concentration gradient or the capability to swell the 
microspore network. .   
pH: 
Triggering the pH-based release of the active from 
microsponge can be achieved by modifying the coating on 
the microsponge. 
Drugs explored in the microsponge delivery system19-22: 
Paracetamol                                 Miconazole  
Benzoyl peroxide                           Curcumin  
Ketoprofen                                     Tretinoin  
Fluconazole                                      Itraconazole                             
 Hydroquinone                                 Mupirocin 
Acyclovir sodium                              Ibuprofen  
Retinol                                              Prednisolone  
Erythromycin                                   Indomethacin  
Polymers used for the preparation of microsponges: 
Eudragit RS 100 and RL 100                Ethylcellulose  
Polystyrene                                           Acrylic polymer  
PHEMA                                                  Carbopol 934  
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 PREPARATION OF MICROSPONGES23, 24, 25, 26: 
 
  
 
 
 
 
 
 
 
                
 
      
Fig. 1: One step and Two step preparation of Microsponge 
 
Drug loading in microsponges can take place in two ways, by 
one-step or two-step process; based on physicochemical 
properties of drug to be loaded. If the drug is typically an 
inert non-polar material, it will create the porous structure 
which is called as porogen. Porogen drug neither hinders the 
polymerization nor become activated and stable to free 
radicals, is entrapped with one-step process. 
 
 Liquid-Liquid Suspension Polymerization25, 26: 
 
Fig.2: Formation of Suspension for the Preparation of Liquid Liquid Suspension Polymerization24 
 
The porous Microsponges are prepared by liquid-liquid 
suspension polymerization method. Polymerization of 
methyl methacrylate or styrene is carried out in round 
bottom flask. The polymerization process leads to formation 
of a reservoir type system, which opens at the surface 
through pores. 
In their preparation, monomers are first dissolved along 
with non-polar active ingredients in a suitable solvent 
solution of monomer and then dispersed in the aqueous 
phase containing additives such as surfactant and 
suspending agents, which are used or help in formation of 
suspension. Once suspension with discrete droplets of the 
desired size is established, polymerization is achieved by 
activating monomers either by catalysis or by increased 
temperature irradiation. 
Drug loading in Microsponge 
One step 
process 
Two step 
process 
Liquid- Liquid suspension 
polymerization 
Quasi emulsion solvent 
diffusion  
Based on the physicochemical properties of the drug 
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Fig.3: Reaction vessel for microsponge preparation by liquid-liquid suspension method25 
1.6.2 Quasi-emulsion Solvent Diffusion27, 28:  
Microsponges are prepared by quasi-emulsion solvent diffusion method using the different polymer quantities.       
 
Fig.4: Preparation of microsponges by quasi-emulsion solvent diffusion method25 
 
In this method external phase and internal phase were used. 
The internal phase is organic phase containing drug, ethyl 
alcohol/acetone (good solvent), polymer and triethyl citrate 
(TEC)/Trichloromethane/Dichloromethane (bridging 
liquid), which was added at an amount of 20% of the 
polymer in order to facilitate the plasticity. The external 
phase mostly consists of distilled water and polyvinyl alcohol 
(PVA). The polymer along with the active, plasticizer and 
diffusible substance (porogen) is poured into an external 
phase, which consists of a polyvinyl alcohol as stabilizer. 
After emulsification, the system is continuously stirred for 2 
hours and maintained at a high temperature if required. 
Then the mixture is filtered to separate the porous 
microsponges. The product is washed and dried in vaccum 
oven at 400C for 12 hours as shown in figure: 4. 
 
Table 1: Optimum values for microsponges formulation 
Sr.no Specification Optimum value 
1 Drug and polymer ratio 1:1,1:2,1:3, 2:1& 3:1 
2 Amount of drug (mg) 100-300 
3 Polyvinylalcohol (mg) 100 
4 Inner phase solvent (ml) Ethyl alcohol 
5 Amount of inner phase solvent 10 
6 Amount of water in outer phase (ml) 100 
7 Temperature of inner phase 25ºC 
8 Type of process Magnetic stirrer and bath sonicator 
9 magnetic stirrer speed 1000 rpm 
 
EVALUATION METHODOLOGY OF MICROSPONGE28-30: 
 Particle size evaluation:  
The particle size distribution is evaluated using optical 
microscope or electron microscope. Particle size 
determination of Microsponge can be performed by laser 
light diffractometry or other suitable method. The values (d 
50) can be expressed for all formulations as mean size 
ranges. Particle size greater than 30 μm can give gritty 
feeling and hence particles sizes between 10 and 25 μm are 
used in the final formulation.  
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Morphology and surface topography: 
 In the morphological study of microsponge topography 
various techniques are used such as the photon correlation 
spectroscopy (Pcs), Transmission electron spectroscopy 
(TEM), scanning electron microscopy (SEM).  
Determination of loading efficiency:  
The loading efficiency (%) of the microsponges can be 
calculated as follows:- 
  Loading efficiency =
                                
                       
     
Determination of production yield: 
 The production yield of the microsponges can be 
determined by:  
    Production Yield = 
                                
                                
×100  
Determination of true density: 
The true density of the microsponge can be measured using 
an ultra-pycnometer in the presence of helium gas and is 
calculated from a mean of repeated determinations.  
Compatibility study: 
It can be studied by thin layer chromatography (TLC) and 
Fourier Transform Infra-red spectroscopy (FT-IR). Effect of 
polymerization on the crystallinity of drug can be studied by 
powder X-ray diffraction (XRD) and differential scanning 
calorimetric.  
Release evaluation: 
Release of microsponges can be controlled through diffusion 
or other triggering mechanism such as moisture, pH, friction, 
temperature. This release mechanism used to enhance 
product aesthetics. 
Resiliency: 
 For the production of bullets a particle that is softer or 
firmer according to the needs of the final formulation 
viscoelastic properties of the microsponge can be modified. 
Increased cross-linking tends to decrease the rate of release.  
Stability study:  
Gel formulation is subject to stability testing as per ICH 
norms. Gel fill in clean, lacquered, collapsible aluminium 
tubes, and various replicates kept at 40 ± 2°C and 75 ± 5% 
relative humidity in a Chamber. Gel assessed for change in 
appearance, pH and in vitro release profile at an interval of 
30, 60 and 90 days. 
APPLICATIONS OF MICROSPONGES30, 31: 
Few applications of microsponge drug delivery system are 
as follows: 
Microsponges in oral care cosmetics: 
The Microsponge system provides the controlled delivery of 
oral medications to the lower gastrointestinal tract, where 
upon exposure to specific enzymes it will be released in the 
colon. It has been shown that microsponge system enhances 
the solubilization of poorly soluble drugs by entrapping 
these drugs in their pores. Itraconazole prepared with 
Eudragit RS100 by using quasi emulsion solvent diffusion 
method for controlled oral delivery and subsequently tablet 
of microsponge was prepared by the direct compression 
method results show that compressibility was improved in 
the physical mixture of the drug and the polymer due to the 
plastic deformation of sponge like microsphere structure31. 
Long lasting coloured cosmetics: 
It is a new application for microsponges. Colours entrapped 
in microsponges may be used in a variety of coloured 
cosmetic products such as lipstics or rouge to make them 
long lasting.  
 Going the natural way using a functional active: 
Although natural actives are important consumer 
attractants, now focus has shifted on using multifunctional 
natural ingredients. 
 
Table 2: Applications of Microsponges32: 
 
Microsponges for Topical Delivery: 
Microsponge consists of a myriad of interconnecting 
voids within a non-collapsible structure that can accept a 
wide variety of substances. The outer surface of 
microsponge is typically porous, allowing the controlled 
flow of substances into and out of the sphere. Several 
primary characteristics, or parameters, of the 
microsponge system can be defined during the 
production phase to obtain spheres that are tailored to 
specific product applications and vehicle compatibility. 
Benzoyl peroxide (BPO) is used for the treatment of acne 
and athletes foot is commonly used in topical 
formulations. Controlled release of the microsponge 
delivery system of BPO to the skin could reduce the side 
effect. 
Microsponge used for bone and tissue engineering: 
 Bone like compounds were obtained by the mixing 
S.No                  Application 
 
                       Advantages 
1. 
 
Anti-acne: Eg: Benzyl Peroxide 
 
Maintained efficacy with decreased skin irritation and 
sensitization. 
2. 
 
Anti-inflammatory: Eg: Hydrocortisone Long lasting activity with reduction of skin allergic response and 
dermatoses. 
3. 
 
  
Sunscreens: 
 
 
Improved protection against sunburns with  long lasting product 
efficacy  and sun related injuries even at elevated concentration 
and with reduced irritancy and sensitization 
4. Anti-dandruffs: Eg: zinc pyrithione, 
selenium sulphide. 
Extended safety and efficacy with reduced unpleasant odour with 
lowered irritation.  
5. Anti-fungals: Sustained release of active ingredients. 
6. Skin depigmenting: Eg: Hydroquinone Improved stabilization against oxidation with improved efficacy 
and aesthetic agents appeal. 
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prepolymerized powder of polymethyl methacrylate 
monomer with two aqueous dispersion of tricalcium 
phosphate grains and calcium deficient hydroxyapatite 
powders. The final compound appeared to be porous and 
developed as microsponge. 
MARKETED FORMULATION USING MDS32, 33: 
It includes Ethical Dermatological Products (APS defined 
ethical dermatological products are prescriptional and non-
prescriptional drugs that are promoted primarily through 
the medical profession for the prevention and treatment of 
skin problems or diseases). Several ethical dermatological 
products approved by US FDA as over the counter (OTC) and 
personal care products are sold in the United States. 
Tretinoin Acne Medication:  
In 1997, the FDA approved the first ethical pharmaceutical 
product which is based on the patented microsponge 
technology. Retin-A-MicroTM, Which has been licensed to 
Ortho-McNeil Pharmaceutical Corporation. However, skin 
irritation among sensitive individuals can limit pateient 
compliance with the prescribed therapy. The company 
belives its patented approach to reduce the potentially 
irritating side effects of tretinoin. 
5-Fluorouracil: 
It is an effective chemotherapeutic agent for the treatment of 
keratosis, hardened skin condition caused by excessive 
exposure to sunlight. However, due to significant side 
effects, patient compliance with the treatment regimen is 
poor.  
Cosmeceutical Product Retinol: 
Retinol is a highly pure form of vitamin A which has 
demonstrated a remarkable ability for maintaining the 
youthful appearance of skin. It becomes unstable when 
mixed with other ingredients. Stabilized retinol in a 
formulation which is cosmetically elegant and which has 
a low potential for skin irritation is successfully 
developed and marketed.  
CONCLUSION 
The microsponge delivery system is a technology of 
controlled release system in which active pharmaceutical 
ingredient is loaded in the macro porous beads and 
initiates reduction in side effects with improved 
therapeutic efficacy. Microsponge can be effectively 
incorporated into topical drug delivery system like gel, 
cream etc. for retention of dosage form on skin. It is also 
use for oral delivery of drugs using bio erodible polymers, 
especially for colon specific delivery.  The microsponge 
drug delivery system is believed to reduce side effects, 
improved stability, increased elegance, enhanced 
formulation flexibility and also offers entrapment of its 
ingredients. Microsponge systems are non-irritating, non-
mutagenic, non-allergenic, and nontoxic. This technology 
is being used currently in cosmetics, over-the-counter 
skin care, sunscreens, and prescription products. This 
kind of drug delivery technology may lead to a better 
understanding of the healing of several diseases. 
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